{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:06:18Z","timestamp":1790262378106,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurophysiologie Clinique\/Clinical Neurophysiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.neucli.2017.02.002","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T03:16:51Z","timestamp":1492053411000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Chronic fatigue syndrome and the immune system: Where are we now?"],"prefix":"10.1016","volume":"47","author":[{"given":"Fane Kojo Fosu","family":"Mensah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amolak Singh","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Cambridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a01","key":"10.1016\/j.neucli.2017.02.002_bib0325","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1093\/clinids\/18.Supplement_1.S130","article-title":"Viral studies of chronic fatigue syndrome","volume":"18","author":"Ablashi","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.neucli.2017.02.002_bib0330","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1176\/appi.ajp.160.2.221","article-title":"Chronic fatigue syndrome: a review","volume":"160","author":"Afari","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neucli.2017.02.002_bib0335","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1080\/17513758.2012.704083","article-title":"Can persistent Epstein-Barr virus infection induce chronic fatigue syndrome as a Pavlov reflex of the immune response?","volume":"6","author":"Agliari","year":"2012","journal-title":"J Biol Dyn"},{"issue":"6","key":"10.1016\/j.neucli.2017.02.002_bib0340","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/0092-8674(88)90419-9","article-title":"Latency comes of age for herpes viruses","volume":"52","author":"Baichwal","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.neucli.2017.02.002_bib0345","first-page":"167","article-title":"Two age peaks in the incidence of chronic fatigue syndrome\/myalgic encephalomyelitis: a population-based registry study from Norway 2008\u20132012","volume":"12","author":"Bakken","year":"2014","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.neucli.2017.02.002_bib0350","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2011.06.016","article-title":"Chronic fatigue syndrome, the immune system and viral infection","volume":"26","author":"Bansal","year":"2012","journal-title":"Brain Behav Immun"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neucli.2017.02.002_bib0355","doi-asserted-by":"publisher","first-page":"S136","DOI":"10.1093\/clinids\/18.Supplement_1.S136","article-title":"Immunologic abnormalities associated with chronic fatigue syndrome","volume":"18","author":"Barker","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.neucli.2017.02.002_bib0360","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/08820139.2015.1015682","article-title":"IgG subclasses and isotypes of VH4-34 encoded antibodies","volume":"44","author":"Bhat","year":"2015","journal-title":"Immunol Invest"},{"issue":"1","key":"10.1016\/j.neucli.2017.02.002_bib0365","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/cei.12043","article-title":"Altered functional B\u00a0cell subset populations in patients with chronic fatigue syndrome compared to healthy controls","volume":"172","author":"Bradley","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.neucli.2017.02.002_bib0370","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in rheumatoid arthritis","volume":"118","author":"Brennan","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neucli.2017.02.002_bib0375","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1479-5876-9-81","article-title":"Immunological abnormalities as potential biomarkers in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"9","author":"Brenu","year":"2011","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.neucli.2017.02.002_bib0380","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/intimm\/dxt068","article-title":"Role of adaptive and innate immune cells in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"26","author":"Brenu","year":"2014","journal-title":"Int Immunol"},{"key":"10.1016\/j.neucli.2017.02.002_bib0385","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1479-5876-10-191","article-title":"Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue","volume":"10","author":"Broderick","year":"2012","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.neucli.2017.02.002_bib0390","doi-asserted-by":"publisher","first-page":"e003973","DOI":"10.1136\/bmjopen-2013-003973","article-title":"Case definitions for chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME): a systematic review","volume":"4","author":"Brurberg","year":"2014","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.neucli.2017.02.002_bib0395","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","article-title":"Myalgic encephalomyelitis: international consensus criteria","volume":"270","author":"Carruthers","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.neucli.2017.02.002_bib0400","doi-asserted-by":"publisher","first-page":"205085","DOI":"10.1155\/2012\/205085","article-title":"Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"2012","author":"Chapenko","year":"2012","journal-title":"Adv Virol"},{"key":"10.1016\/j.neucli.2017.02.002_bib0405","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1479-5876-11-68","article-title":"Screening NK-, B- and T-cell phenotype and function in patients suffering from chronic fatigue syndrome","volume":"11","author":"Curriu","year":"2013","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.neucli.2017.02.002_bib0410","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jcv.2006.08.013","article-title":"Chronic fatigue syndrome","volume":"37","author":"Devanur","year":"2006","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.neucli.2017.02.002_bib0415","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/ije\/dyp147","article-title":"A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping","volume":"38","author":"Dinos","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.neucli.2017.02.002_bib0420","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1479-5876-7-96","article-title":"Plasma cytokines in women with chronic fatigue syndrome","volume":"7","author":"Fletcher","year":"2009","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.neucli.2017.02.002_bib0425","doi-asserted-by":"publisher","first-page":"e10817","DOI":"10.1371\/journal.pone.0010817","article-title":"Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV\/CD26","volume":"5","author":"Fletcher","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.neucli.2017.02.002_bib0430","doi-asserted-by":"publisher","first-page":"e26358","DOI":"10.1371\/journal.pone.0026358","article-title":"Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study","volume":"6","author":"Fluge","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.neucli.2017.02.002_bib0435","doi-asserted-by":"publisher","first-page":"e0129898","DOI":"10.1371\/journal.pone.0129898","article-title":"B-lymphocyte depletion in myalgic encephalopathy\/chronic fatigue syndrome. An open-label phase\u00a0II study with rituximab maintenance treatment","volume":"10","author":"Fluge","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.neucli.2017.02.002_bib0440","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"issue":"7568","key":"10.1016\/j.neucli.2017.02.002_bib0445","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.neucli.2017.02.002_bib0450","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/qjmed\/hcn123","article-title":"Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome","volume":"101","author":"Hoad","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.neucli.2017.02.002_bib0455","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/mp.2015.29","article-title":"Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"21","author":"Hornig","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.neucli.2017.02.002_bib0460","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1400121","article-title":"Distinct plasma immune signatures in ME\/CFS are present early in the course of illness","volume":"1","author":"Hornig","year":"2015","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.neucli.2017.02.002_bib0465","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1542\/peds.2008-1879","article-title":"Chronic fatigue syndrome after infectious mononucleosis in adolescents","volume":"124","author":"Katz","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.neucli.2017.02.002_bib0470","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jpsychores.2015.08.008","article-title":"Capturing the post-exertional exacerbation of fatigue following physical and cognitive challenge in patients with chronic fatigue syndrome","volume":"79","author":"Keech","year":"2015","journal-title":"J Psychosom Res"},{"issue":"6","key":"10.1016\/j.neucli.2017.02.002_bib0475","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/JCM.28.6.1403-1410.1990","article-title":"Immunologic abnormalities in chronic fatigue syndrome","volume":"28","author":"Klimas","year":"1990","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.neucli.2017.02.002_bib0480","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1172\/JCI118990","article-title":"Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome","volume":"98","author":"Konstantinov","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neucli.2017.02.002_bib0485","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cyto.2015.11.018","article-title":"Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"78","author":"Landi","year":"2016","journal-title":"Cytokine"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neucli.2017.02.002_bib0490","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1093\/clinids\/18.Supplement_1.S117","article-title":"Viral studies of chronic fatigue syndrome","volume":"18","author":"Levy","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.neucli.2017.02.002_bib0495","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbi.2015.09.013","article-title":"Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome","volume":"52","author":"Loebel","year":"2016","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.neucli.2017.02.002_bib0500","doi-asserted-by":"publisher","first-page":"e85387","DOI":"10.1371\/journal.pone.0085387","article-title":"Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome","volume":"9","author":"Loebel","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neucli.2017.02.002_bib0505","first-page":"307","article-title":"Xenotropic murine leukemia virus-related virus-associated chronic fatigue syndrome reveals a distinct inflammatory signature","volume":"25","author":"Lombardi","year":"2011","journal-title":"In Vivo"},{"issue":"4","key":"10.1016\/j.neucli.2017.02.002_bib0510","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.autrev.2008.08.003","article-title":"Immunological aspects of chronic fatigue syndrome","volume":"8","author":"Lorusso","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.neucli.2017.02.002_bib0515","first-page":"745","article-title":"In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T\u00a0cell activation","volume":"26","author":"Maes","year":"2005","journal-title":"Neuro Endocrinol Lett"},{"issue":"4","key":"10.1016\/j.neucli.2017.02.002_bib0520","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11011-012-9316-8","article-title":"IgM-mediated autoimmune responses directed against anchorage epitopes are greater in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) than in major depression","volume":"27","author":"Maes","year":"2012","journal-title":"Metab Brain Dis"},{"issue":"3","key":"10.1016\/j.neucli.2017.02.002_bib0525","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2249.2005.02935.x","article-title":"Chronic fatigue syndrome is associated with diminished intracellular perforin","volume":"142","author":"Maher","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.neucli.2017.02.002_bib0530","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/TACG.S99405","article-title":"Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"9","author":"Marshall-Gradisnik","year":"2016","journal-title":"Appl Clin Genet"},{"issue":"6","key":"10.1016\/j.neucli.2017.02.002_bib0535","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/00006842-199411000-00006","article-title":"Psychobehavioral and immunological characteristics of adult people with chronic fatigue and patients with chronic fatigue syndrome","volume":"56","author":"Masuda","year":"1994","journal-title":"Psychosom Med"},{"issue":"5","key":"10.1016\/j.neucli.2017.02.002_bib0540","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1023\/A:1020423124675","article-title":"Psychosocial characteristics and immunological functions in patients with post-infectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome","volume":"25","author":"Masuda","year":"2002","journal-title":"J Behav Med"},{"key":"10.1016\/j.neucli.2017.02.002_bib0545","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/cei.12749","article-title":"Extended B-cell phenotype in patients with myalgic encephalomyelitis\/chronic fatigue syndrome: a cross-sectional study","volume":"184","author":"Mensah","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.neucli.2017.02.002_bib0550","first-page":"477","article-title":"Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T\u00a0lymphocytes and natural killer cells","volume":"28","author":"Mihaylova","year":"2007","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.neucli.2017.02.002_bib0555","series-title":"Chronic fatigue syndrome\/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of chronic fatigue syndrome\/myalgic encephalomyelitis (or encephalopathy) in adults and children","first-page":"1","author":"National Collaborating Centre for Primary Care (UK)","year":"2007"},{"issue":"4","key":"10.1016\/j.neucli.2017.02.002_bib0560","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/08916930802024772","article-title":"Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases","volume":"41","author":"Niller","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.neucli.2017.02.002_bib0565","doi-asserted-by":"publisher","first-page":"359869","DOI":"10.1155\/2012\/359869","article-title":"Human herpesviridae methods of natural killer cell evasion","volume":"2012","author":"Odom","year":"2012","journal-title":"Adv Virol"},{"issue":"3","key":"10.1016\/j.neucli.2017.02.002_bib0570","first-page":"535","article-title":"Excess of activating killer cell immunoglobulin-like receptors and lack of HLA-Bw4 ligands: a two-edged weapon in chronic fatigue syndrome","volume":"4","author":"Pasi","year":"2011","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.neucli.2017.02.002_bib0575","doi-asserted-by":"publisher","first-page":"929720","DOI":"10.1155\/2015\/929720","article-title":"Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"2015","author":"Peterson","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.neucli.2017.02.002_bib0580","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/rheumatology\/kel393","article-title":"Repeated B\u00a0lymphocyte depletion with rituximab in rheumatoid arthritis over 7\u00a0yrs","volume":"46","author":"Popa","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"9507","key":"10.1016\/j.neucli.2017.02.002_bib0585","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0140-6736(06)68073-2","article-title":"Chronic fatigue syndrome","volume":"367","author":"Prins","year":"2006","journal-title":"Lancet"},{"issue":"7230","key":"10.1016\/j.neucli.2017.02.002_bib0590","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/bmj.320.7230.292","article-title":"Chronic fatigue syndrome","volume":"320","author":"Reid","year":"2000","journal-title":"BMJ"},{"issue":"Pt 12","key":"10.1016\/j.neucli.2017.02.002_bib0595","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1099\/0022-1317-77-12-3077","article-title":"Epstein-Barr virus binding to CD21, the virus receptor, activates resting B\u00a0cells via an intracellular pathway that is linked to B\u00a0cell infection","volume":"77","author":"Roberts","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.neucli.2017.02.002_bib0600","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12865-016-0142-3","article-title":"Illness progression in chronic fatigue syndrome: a shifting immune baseline","volume":"17","author":"Russell","year":"2016","journal-title":"BMC Immunol"},{"issue":"12","key":"10.1016\/j.neucli.2017.02.002_bib0605","doi-asserted-by":"publisher","first-page":"e0145453","DOI":"10.1371\/journal.pone.0145453","article-title":"Changes in gut and plasma microbiome following exercise challenge in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"10","author":"Shukla","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neucli.2017.02.002_bib0610","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","article-title":"Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases","volume":"140","author":"Strober","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.neucli.2017.02.002_bib0615","first-page":"225","article-title":"Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome","volume":"12","author":"Tanaka","year":"2003","journal-title":"Int J Mol Med"},{"issue":"6","key":"10.1016\/j.neucli.2017.02.002_bib0620","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-3083.1994.tb03511.x","article-title":"Immunological abnormalities in patients with chronic fatigue syndrome","volume":"40","author":"Tirelli","year":"1994","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.neucli.2017.02.002_bib0625","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.psychres.2005.01.002","article-title":"Cytokine production and modulation: comparison of patients with chronic fatigue syndrome and normal controls","volume":"134","author":"Tomoda","year":"2005","journal-title":"Psychiatry Res"},{"issue":"9","key":"10.1016\/j.neucli.2017.02.002_bib0630","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00018-009-0248-3","article-title":"T helper 17\u00a0cells: discovery, function, and physiological trigger","volume":"67","author":"Torchinsky","year":"2010","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10.1016\/j.neucli.2017.02.002_bib0635","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","article-title":"Epstein-Barr virus in autoimmune diseases","volume":"22","author":"Toussirot","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.neucli.2017.02.002_bib0640","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/art.1780400215","article-title":"High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome","volume":"40","author":"von Mikecz","year":"1997","journal-title":"Arthritis Rheum"}],"container-title":["Neurophysiologie Clinique\/Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0987705317300060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0987705317300060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T13:06:43Z","timestamp":1658927203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0987705317300060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0987705317300060"],"URL":"https:\/\/doi.org\/10.1016\/j.neucli.2017.02.002","relation":{},"ISSN":["0987-7053"],"issn-type":[{"value":"0987-7053","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic fatigue syndrome and the immune system: Where are we now?","name":"articletitle","label":"Article Title"},{"value":"Neurophysiologie Clinique\/Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neucli.2017.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}